Relief by botulinum toxin of voiding dysfunction due to prostatitis

Lancet. 1998 Aug 22;352(9128):625. doi: 10.1016/S0140-6736(05)79580-5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Botulinum Toxins, Type A / therapeutic use*
  • Follow-Up Studies
  • Humans
  • Male
  • Neuromuscular Agents / therapeutic use*
  • Prostatitis / complications*
  • Time Factors
  • Treatment Outcome
  • Urethral Obstruction / drug therapy*
  • Urethral Obstruction / etiology*

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A